NM_006030.4:c.1908-6C>A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006030.4(CACNA2D2):c.1908-6C>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000946 in 1,585,856 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006030.4 splice_region, intron
Scores
Clinical Significance
Conservation
Publications
- cerebellar atrophy with seizures and variable developmental delayInheritance: AR Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- complex neurodevelopmental disorderInheritance: AR Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006030.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CACNA2D2 | NM_006030.4 | MANE Select | c.1908-6C>A | splice_region intron | N/A | NP_006021.2 | |||
| CACNA2D2 | NM_001174051.3 | c.1908-6C>A | splice_region intron | N/A | NP_001167522.1 | ||||
| CACNA2D2 | NM_001005505.3 | c.1908-6C>A | splice_region intron | N/A | NP_001005505.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CACNA2D2 | ENST00000424201.7 | TSL:1 MANE Select | c.1908-6C>A | splice_region intron | N/A | ENSP00000390329.2 | |||
| CACNA2D2 | ENST00000423994.6 | TSL:5 | c.1908-6C>A | splice_region intron | N/A | ENSP00000407393.2 | |||
| CACNA2D2 | ENST00000479441.1 | TSL:1 | c.1908-6C>A | splice_region intron | N/A | ENSP00000418081.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152002Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000495 AC: 1AN: 202180 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000837 AC: 12AN: 1433854Hom.: 0 Cov.: 32 AF XY: 0.00000563 AC XY: 4AN XY: 710498 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152002Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74244 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy Uncertain:1
This sequence change falls in intron 21 of the CACNA2D2 gene. It does not directly change the encoded amino acid sequence of the CACNA2D2 protein. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with CACNA2D2-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at